Douglas E Coltharp sold $5.0M of EHC
EVP & Chief Financial Officer at Encompass Health Corp. 43,575 shares at an average of $115.15, traded Apr 29, 2025, filed Apr 30, 2025.
Score components
- +22RoleCFO
- +25Trade size$5.0M at market
- +10Share of holdings soldSold 42% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001127602-25-012782, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 29, 2025 | MOption exercise Encompass Health Common Stock | +16,075 | $29.06 | $467k | 76,410 | Apr 30, 2025 |
| Apr 29, 2025 | MOption exercise Encompass Health Common Stock | +27,500 | $32.94 | $906k | 103,910 | Apr 30, 2025 |
| Apr 29, 2025 | SOpen-market sale Encompass Health Common Stock | -26,239 | $114.78 | $3.0M | 77,671 | Apr 30, 2025 |
| Apr 29, 2025 | SOpen-market sale Encompass Health Common Stock | -13,402 | $115.51 | $1.5M | 64,269 | Apr 30, 2025 |
| Apr 29, 2025 | SOpen-market sale Encompass Health Common Stock | -3,934 | $116.36 | $458k | 60,335 | Apr 30, 2025 |
| Apr 29, 2025 | MOption exercise Non-qualified Stock Option (Right to Buy)derivative | -16,075 | $0.00 | $0 | 0 | Apr 30, 2025 |
| Apr 29, 2025 | MOption exercise Non-qualified Stock Option (Right to Buy)derivative | -27,500 | $0.00 | $0 | 27,694 | Apr 30, 2025 |
Related signals
Other insiders at Encompass Health Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 27Weak | Encompass Health Corp | John Patrick Darby EVP, Gen Counsel & Secretary | $588k 4,858 shares | -6% | |
| 43Moderate | Encompass Health Corp | Andrew L Price Chief Accounting Officer | $630k 5,211 shares | -7% | |
| 31Weak | EHCsell Encompass Health Corp | Patrick William Tuer EVP, Chief Operating Officer | $126k 1,020 shares | -5% | |
| 48Moderate | Encompass Health Corp | Mark J Tarr President & CEO | $14M 118,384 shares | -18% | |
| 58Moderate | Encompass Health Corp | Elissa Joy Charbonneau Chief Medical Officer | $499k 4,279 shares | -26% | |
| 45Moderate | Encompass Health Corp | John Patrick Darby EVP, Gen Counsel & Secretary | $1.1M 10,000 shares | -11% | |
| 33Weak | EHCsell Encompass Health Corp | Andrew L Price Chief Accounting Officer | $496k 5,042 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.